ISTA PHARMACEUTICALS INC Net Income
ISTA PHARMACEUTICALS INC reported Net Income of -$17.80 million for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-04.
Discontinued › Income Statement
us-gaap:NetIncomeLoss · last filed 2012-05-04
- ISTA PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2012-03-31 was -$17.80M.
- ISTA PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2011-12-31 was -$15.92M.
- ISTA PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2011-09-30 was $30.61M.
- ISTA PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2011-06-30 was $12.78M, a 51.18% decline year-over-year.
- ISTA PHARMACEUTICALS INC net income (loss) attributable to parent for fiscal 2011 was -$56.61M.
- ISTA PHARMACEUTICALS INC net income (loss) attributable to parent for fiscal 2010 was -$5.30M.
- ISTA PHARMACEUTICALS INC net income (loss) attributable to parent for fiscal 2009 was -$57.75M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2012-03-31 | -$17.80M 10-Q · filed 2012-05-04 | -$33.73M derived: sum of 2 quarters · filed 2012-05-04 | -$3.11M derived: sum of 3 quarters · filed 2012-05-04 | $9.66M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-12-31 | -$15.92M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $14.69M derived: sum of 2 quarters · filed 2012-02-27 | $27.47M derived: sum of 3 quarters · filed 2012-02-27 | -$56.61M 10-K · filed 2012-02-27 |
| 2011-09-30 | $30.61M 10-Q · filed 2011-11-07 | $43.39M derived: sum of 2 quarters · filed 2011-11-07 | -$40.69M 10-Q · filed 2011-11-07 | -$49.11M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-06-30 | $12.78M 10-Q · filed 2011-08-01 | -$71.30M 10-Q · filed 2011-08-01 | -$79.72M derived: sum of 3 quarters · filed 2012-05-04 | -$103.24M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-03-31 | -$84.07M 10-Q · filed 2012-05-04 | -$92.50M derived: sum of 2 quarters · filed 2012-05-04 | -$116.02M derived: sum of 3 quarters · filed 2012-05-04 | -$89.85M derived: sum of 4 quarters · filed 2012-05-04 |
| 2010-12-31 | -$8.43M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | -$31.94M derived: sum of 2 quarters · filed 2012-02-27 | -$5.78M derived: sum of 3 quarters · filed 2012-02-27 | -$5.30M 10-K · filed 2012-02-27 |
| 2010-09-30 | -$23.52M 10-Q · filed 2011-11-07 | $2.65M derived: sum of 2 quarters · filed 2011-11-07 | $3.13M 10-Q · filed 2011-11-07 | |
| 2010-06-30 | $26.17M 10-Q · filed 2011-08-01 | $26.64M 10-Q · filed 2011-08-01 | ||
| 2009-12-31 | -$57.75M 10-K · filed 2012-02-27 |